Beyond Brief Intervention: Pharmacologic Management of Alcohol Use Disorder

[1]  F. Naudet,et al.  Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate , 2018, Addiction.

[2]  J. Yager,et al.  The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. , 2018, The American journal of psychiatry.

[3]  J. Mi,et al.  Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults. , 2017, Journal of the American College of Cardiology.

[4]  Nicola Filippini,et al.  Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study , 2017, British Medical Journal.

[5]  Deeksha Elwadhi,et al.  Randomized open-label trial of baclofen for relapse prevention in alcohol dependence , 2017, The American journal of drug and alcohol abuse.

[6]  M. Schaub,et al.  Drinking Goals and Their Association With Treatment Retention and Treatment Outcomes Among Clients in Outpatient Alcohol Treatment , 2017, Substance use & misuse.

[7]  J. Connor.  Alcohol consumption as a cause of cancer , 2017, Addiction.

[8]  N. Ait-Daoud,et al.  Pharmacotherapy for Alcohol Use Disorders: Physicians’ Perceptions and Practices , 2016, Front. Psychiatry.

[9]  B. Winslow,et al.  Medications for Alcohol Use Disorder. , 2016, American family physician.

[10]  Daniel E Falk,et al.  Potential Medications for the Treatment of Alcohol Use Disorder: An Evaluation of Clinical Efficacy and Safety , 2016, Substance abuse.

[11]  K. Asplund,et al.  Drinking resumption: problematic alcohol use relapse after rehabilitation. A phenomenological hermeneutical perspective. , 2015, Scandinavian journal of caring sciences.

[12]  Alex H. S. Harris,et al.  Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC , 2015, Implementation Science.

[13]  A. Heinz,et al.  High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial , 2015, European Neuropsychopharmacology.

[14]  M. Kahan,et al.  Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect. , 2015, Canadian family physician Medecin de famille canadien.

[15]  Abraham Weizman,et al.  Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up. , 2015, Journal of substance abuse treatment.

[16]  J. Finney,et al.  Brief interventions for alcohol misuse , 2015, Canadian Medical Association Journal.

[17]  G. Martinotti,et al.  Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study , 2014, Journal of clinical psychopharmacology.

[18]  D. Kanny,et al.  Contribution of Excessive Alcohol Consumption to Deaths and Years of Potential Life Lost in the United States , 2014, Preventing chronic disease.

[19]  Cassandra J Rowe,et al.  Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. , 2014, JAMA.

[20]  I. Maremmani,et al.  Anticonvulsants for alcohol dependence. , 2014, The Cochrane database of systematic reviews.

[21]  E. Strain,et al.  Pretreatment alcohol drinking goals are associated with treatment outcomes. , 2013, Alcoholism, clinical and experimental research.

[22]  S. Quello,et al.  Gabapentin treatment for alcohol dependence: a randomized clinical trial. , 2014, JAMA internal medicine.